Symptomtext
Flu like systems; Headache; Body aches; Fatigue; Nausea; Painful arm; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Eng6203) via an unspecified route of administration in the right arm on 03Mar2021 at 07:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The medical history included diabetes, fibromyalgia, allergy to opioids and the patient was a breast cancer survivor. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications included metformin (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), losartan potassium (LOSARTIN) and atenolol (MANUFACTURER UNKNOWN), all from unknown dates for unknown indications and unknown if ongoing. The patient previously received tetracycline (MANUFACTURER UNKNOWN), morphine (MANUFACTURER UNKNOWN) and amoxicillin/clavulanic acid (AUGMENTIN) and experienced allergy. On 03Mar2021 at 13:00, the patient experienced flu like symptoms, headache, body aches, fatigue, nausea and painful arm. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events flu like symptoms, headache, body aches, fatigue, nausea and painful arm was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.